Early research (Phase 1)Ended earlyNCT01421927
What this trial is testing
Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma
Who this might be right for
Multiple Myeloma
University Hospital, Bordeaux 13